Palbociclib plus letrozole as treatment for postmenopausal women with hormone receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer for whom letrozole therapy is deemed appropriate: An expanded access study in Australia and India

Sherene Loi, Christos S. Karapetis, Nicole McCarthy, Catherine Oakman, Andrew Redfern, Michelle White, Mustafa Khasraw, Dinesh Chandra Doval, Vinod Gore, Mahmood Alam, Justin Binko, Dongrui Ray Lu, Sindy Kim, Frances Boyle

Research output: Contribution to journal › Article › peer-review

5 Citations (Scopus)
46 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Palbociclib plus letrozole as treatment for postmenopausal women with hormone receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer for whom letrozole therapy is deemed appropriate: An expanded access study in Australia and India'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science